ALT

Latest SEC Filings & News for ALT

1 most recent filing and news item mentioning ALT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ALT/news?limit=20"

Pull ALT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJul 28, 2026Positive

Altimmune Announces Positive Data for Pemvidutide in Alcohol Use Disorder

Altimmune reported positive topline results from its Phase 2 trial of pemvidutide for alcohol use disorder, showing significant reductions in heavy drinking days and favorable safety. The company plans to discuss these data with the FDA.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.